Bar Harbor Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bar Harbor Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.11M	Sell	14,603 -111	-0.8%	-$75.6K	0.49%	57
2026 Q1	$11.4M	Buy	14,714 +18	+0.1%	+$13.8K	0.67%	41
2025 Q4	$11.3M	Buy	14,696 +2,416	+20%	+$1.64M	0.66%	43
2025 Q3	$6.9M	Buy	12,280 +3,304	+37%	+$1.87M	0.41%	64
2025 Q2	$4.71M	Buy	+8,976	New	+$5.01M	0.3%	80
2020 Q4	–	Sell	-1,871	Closed	-$1.05M	–	243
2020 Q3	$1.05M	Sell	1,871 -411	-18%	-$249K	0.12%	113
2020 Q2	$1.42M	Buy	+2,282	New	+$1.3M	0.16%	104

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Bar Harbor Wealth Management's REGN Position: Q2 2026 in Review

Bar Harbor Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.75% in Q2 2026, selling an estimated $75.6K and leaving 14,603 shares worth $9.11M. The position accounts for 0.49% of the portfolio, ranked #57.

Bar Harbor Wealth Management first reported a position in REGN in Q2 2020 and has held it in 7 quarters since. The position peaked at $11.4M in Q1 2026. 349 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Bar Harbor Wealth Management held 14,603 shares of Regeneron Pharmaceuticals worth $9.11M as of Q2 2026.
Bar Harbor Wealth Management sold 111 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $75.6K.
Regeneron Pharmaceuticals made up 0.49% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #57 holding.
Bar Harbor Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
Bar Harbor Wealth Management's Regeneron Pharmaceuticals position peaked at $11.4M in Q1 2026.
349 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.